JOURNAL OF HEART AND LUNG TRANSPLANTATION

Scope & Guideline

Connecting Clinicians and Researchers for a Healthier Tomorrow

Introduction

Delve into the academic richness of JOURNAL OF HEART AND LUNG TRANSPLANTATION with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1053-2498
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1991 to 2024
AbbreviationJ HEART LUNG TRANSPL / J. Heart Lung Transplant.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

The Journal of Heart and Lung Transplantation focuses on advancing the science and practice of organ transplantation, particularly concerning heart and lung procedures. It aims to disseminate groundbreaking research, clinical experiences, and consensus guidelines that shape the future of transplantation practices.
  1. Clinical Outcomes and Patient Management:
    The journal emphasizes studies related to clinical outcomes in heart and lung transplant recipients, focusing on patient management strategies, post-operative care, and long-term follow-up.
  2. Innovative Transplant Techniques and Technologies:
    It highlights advancements in surgical techniques, mechanical circulatory support devices, and organ preservation technologies, showcasing how these innovations improve transplantation success.
  3. Immunology and Rejection Mechanisms:
    Research related to immune responses, including antibody-mediated rejection and the role of different immunosuppressive therapies, is a core focus, exploring how these factors influence graft survival.
  4. Socioeconomic and Racial Disparities:
    The journal addresses disparities in transplantation outcomes based on socioeconomic status and race, aiming to bring attention to inequalities in access to transplant services.
  5. Emerging Therapies and Biomarkers:
    It includes studies on new therapeutic approaches, biomarker identification for predicting rejection, and monitoring graft health, contributing to personalized medicine in transplantation.
The Journal of Heart and Lung Transplantation has been at the forefront of several emerging themes that reflect the current trends in transplantation science and practice. These trends highlight the journal's commitment to addressing contemporary challenges and innovations in the field.
  1. Donor-Derived Cell-Free DNA Monitoring:
    The use of donor-derived cell-free DNA as a biomarker for graft health and rejection surveillance has gained prominence, reflecting an increasing interest in non-invasive monitoring techniques.
  2. Telehealth and Remote Monitoring:
    With the rise of digital health, studies exploring telehealth applications for monitoring transplant recipients and improving patient engagement are trending, particularly in the context of the COVID-19 pandemic.
  3. Holistic Approaches to Patient Care:
    There is a growing emphasis on the psychosocial aspects of transplantation, including caregiver support, mental health interventions, and quality of life assessments for patients.
  4. Personalized Medicine in Transplantation:
    Research focused on tailoring immunosuppressive therapies based on individual patient and donor characteristics is emerging as a crucial area, promoting better outcomes.
  5. Integration of Machine Learning and AI in Transplantation:
    The application of machine learning models to predict transplant outcomes and assess risk factors is becoming increasingly popular, facilitating data-driven decision-making in clinical practice.

Declining or Waning

As the field of organ transplantation evolves, certain themes within the Journal of Heart and Lung Transplantation have shown a decline in focus. This could reflect shifts in clinical priorities, research funding, or advancements in technology that render previously critical areas less prominent.
  1. Traditional Immunosuppression Protocols:
    There is a noticeable decrease in studies focused solely on traditional immunosuppressive regimens, as newer therapies and personalized approaches gain traction.
  2. Longitudinal Studies on Aging Donor Organs:
    Research centered on the aging of donor organs and its effects on transplantation outcomes appears to be waning, possibly overshadowed by advancements in organ preservation and procurement techniques.
  3. Basic Science Studies on Transplant Immunology:
    While fundamental research remains important, there has been a shift towards clinical applications and practical outcomes, resulting in fewer basic science studies being published.
  4. Single-Center Studies:
    As multicenter collaborations become more common, the focus on single-center studies is declining, likely due to the need for broader data to support findings.
  5. Historical Case Studies and Anecdotal Evidence:
    The journal has seen a reduction in the publication of historical case studies as the focus shifts to evidence-based practices and current clinical guidelines.

Similar Journals

Transplant Immunology

Enhancing Understanding Through Cutting-edge Research.
Publisher: ELSEVIERISSN: 0966-3274Frequency: 6 issues/year

Transplant Immunology is a leading interdisciplinary journal published by Elsevier, dedicated to the advancing field of transplant science and immunology. With a strong reputation in the academic community, it currently holds a significant position in the Q3 quartile in both the Immunology and Allergy categories, as well as Q2 in Transplantation, reflecting its impact and relevance within these fields. Since its inception in 1993, the journal has explored a broad spectrum of topics, ranging from immunological mechanisms to clinical aspects of transplantation, serving as a vital resource for researchers, healthcare professionals, and students alike. Although it is not an open-access journal, it offers critical insights and innovative research findings that bridge theoretical knowledge and practical application, thereby enhancing our understanding of transplant immunology. As the field continues to evolve, Transplant Immunology remains committed to publishing high-quality studies that advance the dialogue between immunology and transplantation, fostering collaboration and discovery.

AMERICAN JOURNAL OF TRANSPLANTATION

Empowering healthcare through rigorous transplantation research.
Publisher: ELSEVIER SCIENCE INCISSN: 1600-6135Frequency: 12 issues/year

American Journal of Transplantation, published by Elsevier Science Inc, is a premier academic journal dedicated to the critical field of transplantation. With an impressive impact factor and prestigious rankings in Immunology and Allergy, Pharmacology (medical), and Transplantation, it stands as a leading source of high-quality research in these domains, boasting a Q1 category status since 2023. The journal serves an essential role in advancing scientific knowledge and clinical practices, publishing cutting-edge studies that address pressing issues in organ transplantation and immunology. Researchers, healthcare professionals, and students will find valuable insights through rigorous peer-reviewed articles that focus on innovative methodologies, outcomes, and the latest developments within transplantation science. As the journal continues to evolve from its inception in 2001 to its ongoing contributions through 2024, it remains a key resource for those looking to stay at the forefront of transplantation research and practice.

Annals of Transplantation

Advancing the Future of Transplantation Medicine
Publisher: INT SCIENTIFIC INFORMATION, INCISSN: 1425-9524Frequency: 1 issue/year

Annals of Transplantation is a renowned academic journal published by INT SCIENTIFIC INFORMATION, INC, dedicated to the field of transplantation medicine. With a strong historical presence since its inception in 1996, this journal continues to provide a vital platform for disseminating innovative research, clinical studies, and review articles that contribute significantly to the ever-evolving landscape of organ transplantation. Holding a respectable Q2 ranking in the field of transplantation and a Q3 ranking in broader medicine categories as of 2023, the journal stands out with an impactful repository of knowledge that caters to a diverse audience, including researchers, healthcare professionals, and students. While it currently does not operate under an open access model, the scholarly contributions within are crucial for advancing practices, policies, and outcomes in transplantation. Whether you are seeking to keep abreast of recent advances or looking to publish your own findings, Annals of Transplantation serves as an essential resource for fostering collaboration and innovation in medical science.

TRANSPLANTATION

Advancing the Frontiers of Transplantation Science.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0041-1337Frequency: 12 issues/year

TRANSPLANTATION is a premier journal in the field of organ transplantation, published by Lippincott Williams & Wilkins, that has been a cornerstone of transplantation research since its inception in 1963. With an impressive impact factor cementing its status, this journal is categorized in the top quartile (Q1) of its field, currently ranking 6th out of 54 in the Scopus Medicine Transplantation category, placing it in the 89th percentile. The journal publishes original research, clinical studies, and reviews that significantly advance our understanding of transplantation science, ensuring that professionals, researchers, and students remain informed of the latest developments. Although it is not an open-access journal, it offers valuable insights that contribute to enhancing practice and improving outcomes in transplantation medicine, making it an essential resource for anyone involved in this dynamic and impactful discipline.

Progress in Transplantation

Pioneering Research in Transplantation Science
Publisher: SAGE PUBLICATIONS INCISSN: 1526-9248Frequency: 4 issues/year

Progress in Transplantation is a leading journal published by SAGE Publications Inc, focusing on the dynamic field of transplantation medicine. With an ISSN of 1526-9248 and E-ISSN 2164-6708, this journal serves as a crucial platform for researchers and clinicians aiming to share cutting-edge findings and advancements in organ transplantation. Despite not being an Open Access journal, it provides a significant contribution to the academic community, evidenced by its placement in the Q3 category of Transplantation for 2023 and its ranking of #33 out of 54 in Scopus, showcasing a percentile standing of 39th. Progress in Transplantation has been dedicated to publishing high-quality research since its inception in 2000, and it continues to be a vital resource for those seeking to enrich their knowledge and foster innovation within the field of transplantation, fostering collaboration among practitioners, researchers, and students alike.

Experimental and Clinical Transplantation

Bridging Research and Clinical Practice in Transplantation
Publisher: BASKENT UNIVISSN: 1304-0855Frequency: 6 issues/year

Experimental and Clinical Transplantation is a distinguished journal published by Baskent University in Turkey, dedicated to advancing the field of transplantation through innovative research and clinical insights. Established in 2003, the journal has rapidly gained recognition within the academic community, currently holding a Q3 ranking in the field of Transplantation for 2023, as evidenced by its position in the Scopus ranking for the discipline. With an emphasis on both experimental and clinical studies, this journal serves as a crucial platform for sharing breakthroughs in transplant medicine, immunology, and post-operative care strategies. Although it operates under a restricted access policy, the journal seeks to bridge the gap between research findings and practical applications in clinical settings, making it invaluable for researchers, healthcare professionals, and students alike who are keen on exploring advancements in the transplantation landscape. Through its commitment to quality and innovation, Experimental and Clinical Transplantation contributes significantly to enhancing patient outcomes and fostering scholarly dialogue in the transplantation community.

LIVER TRANSPLANTATION

Pioneering Research in Hepatology and Transplantation.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1527-6465Frequency: 12 issues/year

LIVER TRANSPLANTATION, published by Lippincott Williams & Wilkins, stands at the forefront of hepatology and transplantation research, with a prestigious Q1 rating across the categories of Hepatology, Surgery, and Transplantation as of 2023. Since its inception in 2000, this journal has been dedicated to disseminating high-quality, cutting-edge research that advances the understanding and practice of liver transplantation. With an impressive ranking of 23rd out of 551 in Surgery and 9th out of 54 in Transplantation, it occupies an esteemed position in the academic landscape, attracting contributions from leading experts in the field. The journal's rigorous peer-review process ensures the publication of impactful studies, innovative clinical practices, and vital insights into patient management. By fostering a collaborative environment for researchers, clinicians, and students alike, LIVER TRANSPLANTATION serves as an essential resource for those engaged in the complexities of liver transplantation and related fields. Join the community committed to advancing liver health and transplantation science.

Expert Review of Respiratory Medicine

Elevating Knowledge in Pulmonary Medicine
Publisher: TAYLOR & FRANCIS LTDISSN: 1747-6348Frequency: 6 issues/year

Expert Review of Respiratory Medicine is a leading journal published by Taylor & Francis Ltd, dedicated to advancing the field of respiratory medicine through evidence-based research and comprehensive reviews. With a robust ISSN of 1747-6348 and an E-ISSN of 1747-6356, the journal disseminates essential insights into pulmonary and respiratory health, ranking an impressive #33 in Medicine - Pulmonary and Respiratory Medicine on Scopus, reflecting its significant contribution to this discipline. Established in 2007 and extending its reach through 2024, Expert Review of Respiratory Medicine serves as a crucial resource for professionals and researchers dedicated to improving respiratory health outcomes. Though not designated as an open-access journal, its impactful articles are pivotal in shaping clinical practices and guiding future research in respiratory medicine and related fields, including public health and immunology. By engaging with this journal, readers can stay abreast of the latest developments and critically evaluate advancements in respiratory care.

TRANSPLANT INTERNATIONAL

Leading the Charge in Transplant Innovations
Publisher: FRONTIERS MEDIA SAISSN: 0934-0874Frequency: 1 issue/year

TRANSPLANT INTERNATIONAL is a premier open-access journal in the field of transplantation, published by Frontiers Media SA since 1988. With its dedicated scope encompassing the latest research and advancements in organ transplantation and related fields, this journal serves as an essential resource for researchers, clinicians, and healthcare professionals engaged in transplantation medicine. Boasting an impressive 2023 Scopus rank of #17 out of 54 in the Medicine - Transplantation category and a Q2 quartile ranking, it has established itself as a vital publication platform contributing to the global discourse on transplant innovations. As an open-access journal since 2022, TRANSPLANT INTERNATIONAL enhances the dissemination of knowledge, ensuring that pivotal findings are accessible to a broader audience, thereby fostering advancements in patient care and clinical practices. With its base in Italy and operations managed from Lausanne, Switzerland, the journal promises to remain at the forefront of transplantation research through 2024 and beyond.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Pioneering research for a healthier heart and lungs.
Publisher: MOSBY-ELSEVIERISSN: 0022-5223Frequency: 12 issues/year

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, published by Mosby-Elsevier, stands as a leading peer-reviewed journal dedicated to advancing the fields of thoracic and cardiovascular surgery. With an impressive impact factor reflecting its rigorous standards and significance, this journal occupies prestigious Q1 quartiles in 2023 across Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, as well as Surgery. Additionally, it boasts remarkable rankings in the Scopus database, being placed at #8 in Surgery and #29 in Cardiology and Cardiovascular Medicine, underscoring its pivotal role in disseminating high-quality research and clinical insights. Its scope encompasses vital areas such as surgical techniques, innovative therapies, and patient outcomes, making it an essential resource for researchers, clinicians, and students passionate about advancing cardiac and pulmonary health. Though not an open-access journal, it ensures that subscribers and institutional partners can access valuable research contributions published within its pages from 1959 to 2024. The JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY continues to shape the future of surgical practices and enhance patient care on a global scale.